Analgesics in Kenya delivers standout growth in 2026, with value sales predicted to reach KES32.1 billion in curremt terms, with a robust year-on-year increase of 8%, reflecting a demand profile that is notably resilient against the backdrop of elevated inflation at 6% and a population projected at 58.6 million. This environment is attractive for both established and new entrants, as ongoing reliance on self-medication, driven by limited access to affordable healthcare, ensures sustained high-frequency purchases of pain relief solutions across urban and rural settings. Systemic analgesics, particularly paracetamol and ibuprofen-based brands, anchor this growth through entrenched consumer habits and wide availability, while the rapid uptake of affordable generics and value-focused brands highlights pronounced price sensitivity and opens opportunities for local manufacturers. Companies aiming for success should focus on strengthening local distribution, optimising supply chain resilience to mitigate currency and input cost volatility, and investing in innovation, especially in fast-acting or combination products that address both pain and cold symptoms, while preparing for tighter regulatory scrutiny that will favour trusted brands and formal retail channels.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Kenya with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Kenya, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Kenya report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Kenya?
- Which are the leading brands in Analgesics in Kenya?
- How are products distributed in Analgesics in Kenya?
- How has the regulatory and operating environment for Analgesics changed in Kenya?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Analgesics experience strong growth, driven by early pain management
Systemic pain relief leads usage as generics gain ground
Cetamol boosts pain relief for fever and everyday ailments
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Local players anticipated to expand affordable options as self-medication persists
Systemic pain relief brands set to defend volume as topicals accelerate
Generics and regulatory change expected to reshape value and access landscape
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
GSK Consumer Healthcare builds on trust to widen share lead
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies secure dominance as regulations reinforce trusted access
E-pharmacy platforms build urban presence but offline remains key
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!